You are here » Home » Companies » Alkem Laboratories Ltd - Announcements

Alkem Laboratories Ltd.

BSE: 539523 Sector: Health care
NSE: ALKEM ISIN Code: INE540L01014
BSE 00:00 | 18 Oct 1959.65 44.15
(2.30%)
OPEN

1943.85

HIGH

2029.80

LOW

1939.70

NSE 00:00 | 18 Oct 1958.95 40.10
(2.09%)
OPEN

1920.20

HIGH

2027.90

LOW

1920.10

Announcement under Regulation 30 (LODR)-Press Release / Media Release

August 23, 2019, 6:51 pm | Source: BSE

This is to inform you that US FDA had conducted inspections at the Companys manufacturing facilities located at St. Louis Fenton Park USA from 16th August 2019 to 22nd August 2019 and Baddi India from 19th August 2019 to 23rd August 2019.

At the end of the inspection the Company has received a Form 483 with four (4) observations for the facility located at St. Louis Fenton Park USA and no Form 483 is received for the facility located at Baddi India.

The Company shall put together a detailed response with adequate corrective and preventive measures to address the US FDA Observations for the facility located at St. Louis Fenton Park USA and the same is proposed to be filed within the timeline stipulated by US FDA.

Kindly take note of the same.